Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • Bitcoin USD

    63,748.87
    +2,586.17 (+4.23%)
     

  • CMC Crypto 200

    1,368.11
    +55.49 (+4.23%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • Dow

    37,986.40
    +211.02 (+0.56%)
     

  • Nasdaq

    15,282.01
    -319.49 (-2.05%)
     

  • Gold

    2,406.70
    +8.70 (+0.36%)
     

  • Crude Oil

    83.24
    +0.51 (+0.62%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Laboratory Corporation of America (LH) Q2 2022 Earnings Call Transcript

Motley Fool Transcribing, The Motley Fool
·44-min read
Laboratory Corporation of America (LH) Q2 2022 Earnings Call Transcript

Ladies and gentlemen, thank you for standing by, and welcome to the Labcorp Second quarter 2022 Earnings Call. With me today are Adam Schechter, chairman and chief executive officer; and Glenn Eisenberg, executive vice president and chief financial officer. This morning, in the investor relations section of our website at www.labcorp.com, we posted both a press release and an investor relations presentation with additional information on our business and operations, which includes a reconciliation of the non-GAAP financial measures to the GAAP financial measures discussed during today's call, as well as a presentation on additional information on the spin-off of the clinical development business.

Continue reading